Back to Screener

Healthcare

Kissei Pharmaceutical Co., Ltd.(KSPHF)

Live Price

Offline

$25.77

+0.00% today

1Y Change

-5.01%

Window

Jun 27, 2025 โ†’ Jun 18, 2026

Market Cap
$179.08B
Revenue Growth
+16.9%
EPS Growth
+11.2%
Dividend Yield
3.7%

Coverage: 250 bars ยท Jun 27, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Kissei Pharmaceutical Co., Ltd. (KSPHF) is a Healthcare stock with a market cap of $179.08B and listed on OTC. The stock last traded around $25.77 and down 5.0% across the available one-year price window (Jun 27, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +16.9%, EPS growth of +11.2%, a dividend yield of 3.7%. What stands out right now is revenue +16.9%, EPS +11.2%, free cash flow +142.5% with operating margin -2.3% and ROIC -0.7%. The dividend matters to the case here, with a current yield around 3.7%. Valuation is more restrained than many high-expectation growth names at P/E 12.7 and price/sales 1.9. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines KSPHF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

KSPHF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

KSPHF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

KSPHF Max Drawdown

-19.22%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for KSPHF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedJun 9, 2026Q2
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
Q2
Jun 9, 26
โœ—
0.22
Est 0.48
-54.2%
โ€”
Est โ€”
โ€”
Jun 9
Q1
Feb 2, 26
โœ“
0.87
Est 0.85
+2.4%
โ€”
Est โ€”
โ€”
Feb 2
Q1
Jan 17, 26
โœ—
0.34
Est 0.38
-10.5%
โ€”
Est โ€”
โ€”
Jan 17
Q4
Nov 26, 25
โœ—
-0.62
Est 0.56
-210.7%
โ€”
Est โ€”
โ€”
Nov 26
Q4
Oct 31, 25
โœ“
1.83
Est 1.77
+3.4%
โ€”
Est โ€”
โ€”
Oct 31
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.